OBCI · Ocean Bio Chem Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | $64.30M | $55.56M | $42.26M | $37.94M | $38.93M | $36.21M |
| Cost of Revenue | $40.00M | $32.06M | $26.66M | $695.2K | $22.33M | - |
| Gross Profit | $24.30M | $23.50M | $15.60M | $14.40M | $14.50M | $13.87M |
| R&D | $55.0K | $54.0K | $59.0K | $49.0K | $42.0K | $46.0K |
| SG&A | $9.41M | $8.36M | $7.84M | $7.64M | $7.30M | $7.66M |
| Total Operating Expenses | $13.44M | $11.34M | $10.99M | $10.69M | $10.82M | $10.78M |
| D&A | $1.07M | - | $1.02M | $1.00M | $884.9K | $974.6K |
| Operating Income | $10.86M | $12.16M | $4.61M | $3.71M | $3.68M | $3.10M |
| Interest Expense | $148.6K | $132.5K | $118.6K | ($2.1K) | - | $17.8K |
| Income Tax | $2.31M | $2.62M | $996.0K | $791.0K | $1.07M | $983.2K |
| Net Income | $8.40M | $9.62M | $3.50M | $2.80M | $2.60M | $2.10M |
| EPS - Basic | $0.89 | $1.02 | $0.37 | $0.30 | $0.28 | $0.23 |
| EPS - Diluted | $0.89 | $1.02 | $0.37 | $0.30 | $0.28 | $0.23 |
Balance Sheet
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $12.68M | $11.12M | $6.13M | $1.40M | $2.42M | $4.07M |
| Accounts Receivable | $9.54M | $8.33M | $7.13M | $5.66M | $4.96M | $4.93M |
| Inventory | $16.82M | $13.18M | $9.56M | $12.09M | $9.07M | $8.60M |
| Accounts Payable | $2.88M | $1.97M | $1.05M | $1.47M | $1.81M | $1.51M |
| Current Assets | $42.35M | $35.86M | $26.65M | $23.54M | $21.80M | $19.81M |
| Total Assets | $60.28M | $47.90M | $38.29M | $35.23M | $31.99M | $25.67M |
| Current Liabilities | $4.65M | $3.70M | $2.83M | $3.01M | $2.86M | $2.89M |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $12.84M | $7.99M | $7.55M | $7.80M | $7.09M | $3.16M |
| Stockholders' Equity | $47.44M | $39.91M | $30.73M | $27.43M | $24.90M | $22.52M |
| Retained Earnings | $36.56M | $29.29M | $20.43M | $17.40M | $15.16M | $13.11M |
Cash Flow
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.51M | $6.21M | $5.99M | $1.22M | $2.93M | $3.03M |
| Investing Cash Flow | ($7.44M) | ($1.35M) | ($793.5K) | ($1.74M) | ($8.02M) | ($443.9K) |
| Financing Cash Flow | $3.02M | ($1.27M) | ($923.9K) | ($913.3K) | $3.44M | ($978.5K) |
| CapEx | $7.44M | $1.84M | $718.5K | $1.36M | $5.28M | $443.9K |
| Free Cash Flow | ($1.94M) | $4.37M | $5.27M | ($140.7K) | ($2.35M) | $2.58M |
Ratios
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 37.8% | 42.3% | 36.9% | 37.9% | 37.2% | 38.3% |
| Operating margin | 16.9% | 21.9% | 10.9% | 9.8% | 9.4% | 8.6% |
| EBITDA margin | 18.6% | - | 13.3% | 12.4% | 11.7% | 11.2% |
| Net margin | 13.1% | 17.3% | 8.3% | 7.4% | 6.7% | 5.8% |
| Free cash flow margin | -3.0% | 7.9% | 12.5% | -0.4% | -6.0% | 7.1% |
| FCF / Net income | -0.23 | 0.45 | 1.51 | -0.05 | -0.90 | 1.23 |
| R&D / Revenue | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| SG&A / Revenue | 14.6% | 15.0% | 18.6% | 20.1% | 18.7% | 21.2% |
| Effective tax rate | 21.5% | 21.4% | 22.2% | 22.1% | 29.2% | 31.9% |
| Return on assets | 13.9% | 20.1% | 9.1% | 7.9% | 8.1% | 8.2% |
| Return on equity | 17.7% | 24.1% | 11.4% | 10.2% | 10.5% | 9.3% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 9.11 | 9.70 | 9.42 | 7.83 | 7.63 | 6.85 |
| Quick ratio | 5.49 | 6.14 | 6.04 | 3.81 | 4.45 | 3.88 |
| Cash ratio | 2.73 | 3.01 | 2.17 | 0.47 | 0.85 | 1.41 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | 73.1x | 91.8x | 38.9x | -1795.7x | - | 173.7x |
| Equity multiplier | 1.27 | 1.20 | 1.25 | 1.28 | 1.28 | 1.14 |
| Liabilities / Assets | 0.21 | 0.17 | 0.20 | 0.22 | 0.22 | 0.12 |
| Efficiency | ||||||
| Asset turnover | 1.07 | 1.16 | 1.10 | 1.08 | 1.22 | 1.41 |
| Inventory turnover | 2.38 | 2.43 | 2.79 | 0.06 | 2.46 | - |
| Days sales outstanding | 54d | 55d | 62d | 54d | 47d | 50d |
| Days inventory outstanding | 153d | 150d | 131d | 6346d | 148d | - |
| Days payable outstanding | 26d | 22d | 14d | 773d | 30d | - |
| Cash conversion cycle | 181d | 182d | 178d | 5627d | 165d | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 15.7% | 31.5% | 11.4% | -2.5% | 7.5% | 6.5% |
| Revenue CAGR (3y) | 19.2% | 12.6% | 5.3% | 3.7% | 4.7% | 3.4% |
| Revenue CAGR (5y) | 12.2% | 10.3% | 4.5% | 3.0% | 4.6% | 2.7% |
| Gross profit growth (YoY) | 3.4% | 50.6% | 8.4% | -0.7% | 4.5% | 22.3% |
| Operating income growth (YoY) | -10.7% | 163.7% | 24.4% | 0.9% | 18.7% | 313.1% |
| Net income growth (YoY) | -12.6% | 174.9% | 25.2% | 7.4% | 24.3% | 354.8% |
| EPS growth (YoY) | -12.7% | 175.7% | 23.3% | 7.1% | 21.7% | 360.0% |
| EPS CAGR (3y) | 43.7% | 53.9% | 17.2% | 81.7% | 6.8% | 10.6% |
| EPS CAGR (5y) | 31.1% | 82.8% | 10.0% | 12.0% | 4.0% | -0.8% |
| FCF growth (YoY) | - | -17.1% | - | 94.0% | - | - |
| FCF CAGR (5y) | - | - | 40.7% | - | - | 9.0% |
| Book value growth (YoY) | 18.9% | 29.8% | 12.0% | 10.2% | 10.6% | 9.1% |
Stability scores
Altman Z′
FY 2021 · bankruptcy risk
4.14
Safe
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2021 · 9-point quality
3/9
Weak
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✗Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✗Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Specialty Cleaning, Polishing and Sanitation Preparations
Comparing OCEAN BIO CHEM INC against the 4 most active filers in the same SIC group.